HOME > > Products > PRONULIFE® (Probiotic) > PRONULIFE® RenaProtect
PRONULIFE® RenaProtect
PRONULIFE® RenaProtect: Clinically Supported Probiotic Leader for Kidney Health
Chronic Kidney Disease (CKD) is a growing global health burden. According to the World Health Organization (WHO), kidney diseases rose to become the 10th leading cause of death worldwide in 2019. The silent nature of early-stage CKD often delays diagnosis and management. While conventional therapies can slow disease progression, they are often associated with side effects and patient compliance issues—highlighting the urgent need for safe and scientifically supported adjunctive solutions.
With rising patient numbers and increasing public awareness of kidney health, functional probiotics have emerged as a promising adjunctive approach in CKD management. PRONULIFE® RenaProtect, developed with patented strains and advanced research, offers a clinically supported natural solution for proactive kidney health.
Unlocking the Gut-Kidney Axis
Clinically Supported Formula: PRONULIFE® RenaProtect
Multiple studies demonstrate that PRONULIFE® RenaProtect:
• Helps slow the decline of kidney function
• Promotes healthier gut microbiota composition
• Is associated with reduced endotoxin and pro-inflammatory markers in the blood
• Supports overall health indicators in CKD patients
Formulation Information
Core Advantages
Patents
📩 For technical data, customization inquiries, or formulation partnerships, contact us at:
📧 glac@glac.com.tw
Further Reading: PRONULIFE® Functional Probiotic Ingredients🔙
References
Chronic Kidney Disease (CKD) is a growing global health burden. According to the World Health Organization (WHO), kidney diseases rose to become the 10th leading cause of death worldwide in 2019. The silent nature of early-stage CKD often delays diagnosis and management. While conventional therapies can slow disease progression, they are often associated with side effects and patient compliance issues—highlighting the urgent need for safe and scientifically supported adjunctive solutions.
With rising patient numbers and increasing public awareness of kidney health, functional probiotics have emerged as a promising adjunctive approach in CKD management. PRONULIFE® RenaProtect, developed with patented strains and advanced research, offers a clinically supported natural solution for proactive kidney health.
Unlocking the Gut-Kidney Axis
- The gut microbiota and kidney function are interconnected through bidirectional regulation, mediated by microbial metabolites and immune responses.
- Beneficial bacteria produce metabolites such as short-chain fatty acids (SCFAs) and indole derivatives, which help suppress inflammation, reinforce the gut barrier, and support systemic kidney protection.
- Pathogenic bacteria, in contrast, generate harmful compounds that disrupt the intestinal barrier, increasing endotoxin and uremic toxin levels that place additional stress on the kidneys.
- Maintaining a balanced gut microbiota can help mitigate chronic inflammation and toxic burden associated with CKD.
Clinically Supported Formula: PRONULIFE® RenaProtect
Multiple studies demonstrate that PRONULIFE® RenaProtect:
• Helps slow the decline of kidney function
• Promotes healthier gut microbiota composition
• Is associated with reduced endotoxin and pro-inflammatory markers in the blood
• Supports overall health indicators in CKD patients
Formulation Information
| Ingredien | Strain | Functional Role |
| PRONULIFE® RenaProtect | L. acidophilus TYCA06 | Supports gut barrier and immune modulation |
| B. longum subsp. infantis BLI-02 | Modulates inflammation and gut microbiota balance | |
| B. bifidum VDD088 | Helps reduce toxin production and supports kidney health |
Core Advantages
- Supports kidney health: Modulates the gut–kidney axis and is associated with reduced endotoxin and inflammatory factors in circulation
- Improves tolerance: Helps alleviate gastrointestinal discomfort often reported by patients on long-term kidney-related medication
- Microbiota modulation: Rebuilds a healthier gut microbiome to ease chronic inflammation and reduce toxic load
Patents
- TW I701034｜Pharmaceutical and food composition of lactic acid bacteria strains for supporting kidney health and reducing inflammation
- US 10993973 B2｜Pharmaceutical and food composition of lactic acid bacteria strains for supporting kidney health and reducing inflammation
📩 For technical data, customization inquiries, or formulation partnerships, contact us at:
📧 glac@glac.com.tw
Further Reading: PRONULIFE® Functional Probiotic Ingredients🔙
